Ergomed’s fast-growing services business includes an industry-leading suite of specialist pharmacovigilance solutions, integrated under the PrimeVigilance brand and a full range of high-quality clinical research and trial management services under the Ergomed Clinical Research brand.  The Ergomed group employs over 1,800 people and operates out of 24 offices around the world, providing its services to researchers and patients in around 100 countries globally.

Our Ergomed Clinical Research business was founded in 1997 and provides high-quality clinical research and trial management services globally and across all trial phases (I to IV), specialising in oncology and rare disease trials.  We use innovative site-support services which focus on enhancing patient recruitment and engagement, with a strong heritage in Europe and the USA.

PrimeVigilance is a global leader in pharmacovigilance and specialised multi-lingual medical information services. Since 2008, the PrimeVigilance business has supported pharmaceutical, biotechnology and genetics companies in managing the global safety of their products, all the way from clinical trial to post-marketing.  Our pharmacovigilance services include case processing, signal and risk management, pharmacoepidemiology, audits, training, advisory literature services, medical information and QPPV.